Biovie (BIVI) Return on Equity [ROE] (2017 - 2026)
Biovie's Return on Equity [ROE] was -170.59% in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 84.66 percentage points from -85.93% a year earlier and down 56.37 percentage points from the prior quarter.
Powered by 
Analysis
Biovie (BIVI) Return on Equity [ROE] (2017 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Return on Equity [ROE] at Biovie came in at -150.76%, down 49.12 percentage points from FY2025.
- Return on Equity [ROE] shows a four-year change of +447.42 percentage points (FY2022 to FY2026).
- In earlier fiscal years, Return on Equity [ROE] was -101.64% in FY2025 (+106.62 pp), -208.26% in FY2024 (+320.44 pp), -528.70% in FY2023 (+69.49 pp) and -598.18% in FY2022.
- The fiscal Q4 2026 figure marks the lowest quarterly Return on Equity [ROE] since fiscal Q1 2025.
- Compared with a year earlier, Return on Equity [ROE] was higher in six of the last eight quarters, with an average year-over-year change of +128.82 percentage points.
- The best year-over-year quarter for Return on Equity [ROE] over five years was fiscal Q4 2022 (a gain of 1200.47 percentage points); the worst was fiscal Q3 2022 (a drop of 1003.31 percentage points).
- Per Business Quant data, BIVI's Return on Equity [ROE] in the three fiscal quarters before Q4 2026 was -114.22% (Q3 2026), -78.91% (Q2 2026) and -84.12% (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Biovie | 11.46 Mn | 11.46 Mn | - | -170.59% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -170.59% |
| Mar 31, 2026 | -114.22% |
| Dec 31, 2025 | -78.91% |
| Sep 30, 2025 | -84.12% |
| Jun 30, 2025 | -85.93% |
| Mar 31, 2025 | -83.05% |
| Dec 31, 2024 | -127.79% |
| Sep 30, 2024 | -172.87% |
| Jun 30, 2024 | -186.57% |
| Mar 31, 2024 | -274.76% |
| Dec 31, 2023 | -575.36% |
| Sep 30, 2023 | -441.72% |
| Jun 30, 2023 | -271.22% |
| Mar 31, 2023 | -206.05% |
| Dec 31, 2022 | -257.47% |
| Sep 30, 2022 | -642.85% |
| Jun 30, 2022 | -382.87% |
| Mar 31, 2022 | -1,149.34% |
| Dec 31, 2021 | -801.56% |
| Sep 30, 2021 | -1,132.10% |
API Access
Biovie Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BIVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "BIVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BIVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();